4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-057799
Director bought 57,369 shares at an average $1.01 ($58,134)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamond David Director | 2023-12-05 | Purchase | +19,123 | $1.01 | $19,314 | 2,241,418 | I |
| Lamond David Director | 2023-12-06 | Purchase | +19,123 | $1.02 | $19,505 | 2,260,541 | I |
| Lamond David Director | 2023-12-07 | Purchase | +19,123 | $1.01 | $19,314 | 2,279,664 | I |
| Open-market purchases · 57,369 sh · avg $1.01 · $58,134 | |||||||
Loading xslF345X05/doc4.xml…